Recursion Pharmaceuticals director Blake Borgeson reports sale of $155,200 in common shares
RXRX•Director Blake Borgeson sold 40,000 Recursion Pharmaceuticals Class A common shares on November 3, 2026, at $3.88 per share, leaving him with direct ownership of 6,068,287 shares.
1. Share sale
Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals Class A common stock on November 3, 2026, at $3.88 per share. He retained direct ownership of 6,068,287 shares.
